European regulatory committee rejects Lilly's Alzheimer's disease treatment due to potential risks of brain bleeding and ...

Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a type of ...

The European Union’s health regulator on Friday rejected Eli Lilly’s (LLY) Alzheimer’s drug, Kisunla, citing risks of brain ...

A European regulatory committee has rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially ...

PTC Therapeutics said on Friday the European Commission will remove its inherited progressive muscle-wasting disorder from the region after an advisory panel reaffirmed a negative opinion of the drug ...

A new kind of pharma-telehealth partnership has come under scrutiny over concerns that such an arrangement could lead to ...

Novo Nordisk leads a GLP-1 agonist market that could surpass $150 billion by 2035. Ironically, the market is passing on the stock right now. Should you?

Daisy Edgar-Jones said in an interview with Elle Magazine that she is quite fortunate her A-list male co-stars have never ...

Then at the beginning of 2024, supplies of insulin ran short due to production issues at Eli Lilly, one of the three companies responsible for over 90% of the U.S. insulin market. And in the second ...

President Donald Trump announced Friday that Boeing will build the Air Force’s future fighter jets, which the Pentagon says ...

Copycat versions of Eli Lilly's diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They're ...

BEIJING (AP) — U.S. Sen. Steve Daines, a strong supporter of President Donald Trump, has met a senior Chinese diplomat in ...